4.7 Article

Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala

Journal

JOURNAL OF NEUROSCIENCE
Volume 24, Issue 37, Pages 8161-8169

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2574-04.2004

Keywords

beta-adrenoceptor; corticosterone; emotional arousal; glucocorticoid receptor; norepinephrine; propranolol; atenolol; RU 28362; stress hormone; spatial memory; xamoterol

Categories

Funding

  1. NIMH NIH HHS [R56 MH012526, R01 MH012526, MH12526] Funding Source: Medline

Ask authors/readers for more resources

Previous findings indicate that administration of a beta-adrenoceptor antagonist systemically blocks glucocorticoid impairment of memory retrieval. Here, we report that beta-adrenoceptor activation in the hippocampus and the basolateral complex of the amygdala (BLA) is implicated in the impairing effects of glucocorticoids on memory retrieval. The specific glucocorticoid receptor (GR) agonist 11beta,17beta-dihydroxy- 6,21-dimethyl-17alpha-pregna-4,6-trien-20yn-3-one (RU 28362) ( 15 ng) infused into the hippocampus of male Sprague Dawley rats 60 min before water maze retention testing, 24 hr after training, impaired probe trial retention performance, as assessed by quadrant search time and initial latency to cross the platform location. Because we found previously that RU 28362 infused into the hippocampus does not affect water maze acquisition or immediate recall, the findings suggest that the GR agonist-induced retention impairment was attributable to a selective influence on long-term memory retrieval. Likewise, systemic injections of the beta(1)-adrenoceptor partial agonist xamoterol (3.0 or 10.0 mg/kg, s.c.) 60 min before the probe trial dose-dependently impaired retention performance. The beta-adrenoceptor antagonist propranolol (2.0 mg/kg) administered subcutaneously before retention testing did not affect retention performance alone, but blocked the memory retrieval impairment induced by concurrent intrahippocampal infusions of RU 28362. Pretest infusions of the beta(1)-adrenoceptor antagonist atenolol into either the hippocampus (1.25 mug in 0.5 mul) or the BLA ( 0.5 mug in 0.2 mul) also prevented the GR agonist-induced memory retrieval impairment. These findings suggest that glucocorticoids impair retrieval of long-term spatial memory by facilitating noradrenergic mechanisms in the hippocampus, and additionally, that norepinephrine-mediated BLA activity is critical in enabling hippocampal glucocorticoid effects on memory retrieval.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available